Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397573
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-04-30
Brief Title:
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Sponsor:
Baptist Health South Florida
Organization:
Baptist Health South Florida
Study Overview
Official Title:
Phase 1 Trial of Ablative Stereotactic MR-Guided Adaptive Reirradiation for Abdominal and Pelvic Tumors
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy called reirradiation or reRT The researchers want to find out what effects good and bad reRT has in people with cancer in the abdomen and pelvis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None